AVANÇOS PROMISSORES NA OTIMIZAÇÃO DO TRATAMENTO DE AUTISMO: EXPLORANDO ABORDAGENS E ESTRATÉGIAS EFETIVAS
DOI:
https://doi.org/10.61164/rmnm.v13i1.1989Palabras clave:
Transtorno Autístico, Transtorno do Espectro Autista, Tratamento Farmacológico, diagnóstico.Resumen
El diagnóstico precoz es fundamental para permitir intervenciones tempranas, favoreciendo la mejora del cuadro clínico y el desarrollo del individuo. Además de los enfoques farmacológicos, las terapias conductuales, ocupacionales y del habla también juegan un papel fundamental en el tratamiento del TEA. A pesar de la ausencia de medicamentos eficaces para los síntomas centrales del autismo, se han utilizado algunos medicamentos para ayudar a los pacientes a enfrentar desafíos y mejorar su calidad de vida. Es fundamental que exista un seguimiento multidisciplinario para garantizar un tratamiento personalizado y seguro, involucrando a un equipo multidisciplinario, combinando terapias conductuales, ocupacionales y del habla, con el uso adecuado de medicamentos cuando sea necesario. El objetivo de este estudio es identificar los tratamientos para el trastorno del espectro autista (TEA) que tengan la mayor evidencia y efectividad. La investigación se realizó mediante una revisión bibliográfica basada en el tema mencionado. Sin embargo, aún es necesario investigar nuevos tratamientos farmacológicos y el desarrollo de medicamentos específicos para el TEA, con el objetivo de mejorar la calidad de vida y la inclusión social de las personas.
Descargas
Referencias
AL-DEWIK, N. I. Risk factors diagnosis, prognosis and treatment of autism. Frontiers in Bioscience, v. 25, n. 9, p. 1682–1717, 2020. DOI: https://doi.org/10.2741/4873
ALMEIDA, M. S. C. et al. Classificação Internacional das Doenças – 11 revisão. Revista de Saúde Pública, v. 54, p. 104, 14 dez. 2020. DOI: https://doi.org/10.11606/s1518-8787.2020054002120
AMERICAN PSYCHIATRIC ASSOCIATION. Manual Diagnóstico e Estatístico de Transtornos Mentais - DSM-5-TR. Porto Alegre, Artmed, 2023.
AUTISTIC PERSONS. ID on line Revista de psicologia, v. 15, n. 56, p. 163–175, 31 jul. 2021. DOI: https://doi.org/10.14295/idonline.v15i56.3131
BRITO, N. O. R. et al. Avaliação da eficácia da Risperidona comparada ao placebo e ao Aripiprazol no tratamento da agressividade em pacientes autistas: revisão sistemática. repositório.aee.edu.br, 21 jun. 2021.
ECKES, T. et al. Comprehensive ABA-based interventions in the treatment of children with autism spectrum disorder – a meta-analysis. BMC Psychiatry, v. 23, n. 1, 2 mar. 2023. DOI: https://doi.org/10.1186/s12888-022-04412-1
MASINI, E. et al. An Overview of the Main Genetic, Epigenetic and Environmental Factors Involved in Autism Spectrum Disorder Focusing on Synaptic Activity. International Journal of Molecular Sciences, v. 21, n. 21, p. 8290, 5 nov. 2020. DOI: https://doi.org/10.3390/ijms21218290
OLIVEIRA, C. A. DE et al. Eficácia do uso da Fluoxetina no Tratamento do Transtorno dos Comportamentos Obsessivo-Compulsivo em Autistas / Effectiveness of Fluoxetine use in the Treatment of Obsessive-Compulsive Behavior Disorders in
OSHIMA, F. et al. Cognitive behavior therapy for autistic adolescents, awareness and care for my autistic traits program: a multicenter randomized controlled trial. BMC Psychiatry, v. 23, p. 661, 7 set. 2023. DOI: https://doi.org/10.1186/s12888-023-05075-2
PEREIRA, E. T. et al. Comunicação alternativa e aumentativa no transtorno do espectro do autismo: impactos na comunicação. CODAS, v. 32, n. 6, 2020. DOI: https://doi.org/10.1590/2317-1782/20202019167
REIS, R. DE C. et al. Association of Parental Support with Reduced Stereotypy in Children with Autism Spectrum Disorder: A Cross-Sectional Study. Medicina, v. 59, n. 9, p. 1667, 15 sets. 2023. DOI: https://doi.org/10.3390/medicina59091667
REYES, E.; PIZARRO, L. Rol de la terapia farmacológica en los trastornos del espectro autista. Revista Médica Clínica Las Condes, v. 33, n. 4, p. 387–399, jul. 2022. DOI: https://doi.org/10.1016/j.rmclc.2022.07.002
ROSEN, N. E.; LORD, C.VOLKMAR, F.O.R. The Diagnosis of Autism: From Kanner to DSM-III to DSM-5 and Beyond. Journal of Autism and Developmental Disorders, v. 51, n. 12, 24 fev. 2021. DOI: https://doi.org/10.1007/s10803-021-04904-1
RUGGIERI, V. Autismo. Pharmacological treatment. Medicina, v. 83 Suppl 4, p. 46–51, 1 set. 2023.
SILVA, A. R. C. E. DA; BATISTA, D. C. DE À. Distúrbios comportamentais associados ao transtorno do espectro autista (TEA) - tratamento farmacológico e o manejo clínico de reações adversas. Revista Multidisciplinar do Sertão, v. 4, n. 3, p. 276–285, 30 set. 2022.
VIANA, A. C. V. et al. Autismo: Saúde dinâmica, v. 2, n. 3, p. 1–18, 18 nov. 2020. DOI: https://doi.org/10.4322/2675-133X.2022.017
XIONG, M. et al. Efficacy of Melatonin for Insomnia in Children with Autism Spectrum Disorder: A Meta-analysis. Neuropediatrics, v. 54, n. 3, p. 167–173, 24 fev. 2023. DOI: https://doi.org/10.1055/s-0043-1761437
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2023 Revista Multidisciplinar do Nordeste Mineiro
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
